• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

英国医院重症监护病房患者中革兰氏阳性菌对抗菌药物的敏感性

Susceptibility of Gram-positive bacteria from ICU patients in UK hospitals to antimicrobial agents.

作者信息

Johnson A P, Henwood C, Mushtaq S, James D, Warner M, Livermore D M

机构信息

Antibiotic Resistance Monitoring and Reference Laboratory, Central Public Health Laboratory, Colindale, London, UK.

出版信息

J Hosp Infect. 2003 Jul;54(3):179-87. doi: 10.1016/s0195-6701(03)00145-2.

DOI:10.1016/s0195-6701(03)00145-2
PMID:12855232
Abstract

Microbiologists in 25 sentinel laboratories were each asked to refer up to 100 clinically-significant Gram-positive bacteria isolated from consecutive intensive care unit (ICU) patients. A total of 1595 isolates were collected from patients in 23 hospitals; these included Staphylococcus aureus (47.6%), coagulase-negative staphylococci (CNS) (30.6%), enterococci (14.3%), pneumococci (2.8%) and other streptococci (3.5%). A few coryneforms, other bacilli and a Nocardia sp. were also collected. Rates of oxacillin resistance among S. aureus and CNS isolates were 59.3 and 78.5%, respectively. Vancomycin-resistant S. aureus were not detected, although two isolates (0.3%) were resistant to teicoplanin [minimum inhibitory concentrations (MICs) 8 mg/L]. In contrast, 13.7% of CNS were teicoplanin resistant (MICs 8-32 mg/L) and 1.2% were resistant to vancomycin. Among the enterococci, 72.5% were Enterococcus faecalis and 24.5% were Enterococcus faecium, the remainder including isolates of Enterococcus casseliflavus or Enterococcus gallinarum. Eighteen percent of E. faecium isolates were vancomycin-resistant, compared with only 3% of E. faecalis isolates. Rates of high-level gentamicin resistance in E. faecalis and E. faecium were 40 and 25%, respectively. Nine percent of pneumococci and streptococci were resistant to penicillin, with 7 and 11%, respectively, resistant to erythromycin. None of the isolates showed resistance to linezolid, with the MICs for the entire study population falling in the range of 0.5-4 mg/L.

摘要

来自25个哨点实验室的微生物学家每人被要求提交从连续的重症监护病房(ICU)患者中分离出的多达100株具有临床意义的革兰氏阳性菌。共从23家医院的患者中收集到1595株分离菌;其中包括金黄色葡萄球菌(47.6%)、凝固酶阴性葡萄球菌(CNS)(30.6%)、肠球菌(14.3%)、肺炎球菌(2.8%)和其他链球菌(3.5%)。还收集到一些棒状杆菌、其他杆菌和1株诺卡氏菌。金黄色葡萄球菌和CNS分离株中苯唑西林耐药率分别为59.3%和78.5%。未检测到耐万古霉素金黄色葡萄球菌,不过有2株分离菌(0.3%)对替考拉宁耐药[最低抑菌浓度(MIC)8 mg/L]。相比之下,13.7%的CNS对替考拉宁耐药(MIC 8 - 32 mg/L),1.2%对万古霉素耐药。在肠球菌中,72.5%为粪肠球菌,24.5%为屎肠球菌,其余包括鹑鸡肠球菌或卡西菲肠球菌分离株。18%的屎肠球菌分离株对万古霉素耐药,而粪肠球菌分离株仅有3%耐药。粪肠球菌和屎肠球菌中高水平庆大霉素耐药率分别为40%和25%。9%的肺炎球菌和链球菌对青霉素耐药,对红霉素耐药的分别为7%和11%。所有分离株对利奈唑胺均无耐药,整个研究人群的MIC值在0.5 - 4 mg/L范围内。

相似文献

1
Susceptibility of Gram-positive bacteria from ICU patients in UK hospitals to antimicrobial agents.英国医院重症监护病房患者中革兰氏阳性菌对抗菌药物的敏感性
J Hosp Infect. 2003 Jul;54(3):179-87. doi: 10.1016/s0195-6701(03)00145-2.
2
Susceptibility of gram-positive cocci from 25 UK hospitals to antimicrobial agents including linezolid. The Linezolid Study Group.来自英国25家医院的革兰氏阳性球菌对包括利奈唑胺在内的抗菌药物的敏感性。利奈唑胺研究小组。
J Antimicrob Chemother. 2000 Dec;46(6):931-40. doi: 10.1093/jac/46.6.931.
3
Antimicrobial susceptibility of the pathogens of bacteraemia in the UK and Ireland 2001-2002: the BSAC Bacteraemia Resistance Surveillance Programme.2001 - 2002年英国和爱尔兰血流感染病原体的抗菌药物敏感性:英国抗菌化疗学会血流感染耐药性监测项目
J Antimicrob Chemother. 2004 Jun;53(6):1018-32. doi: 10.1093/jac/dkh232. Epub 2004 May 5.
4
Clinical relevance of a European collaborative study on comparative susceptibility of gram-positive clinical isolates to teicoplanin and vancomycin.一项关于革兰氏阳性临床分离株对替考拉宁和万古霉素的比较敏感性的欧洲合作研究的临床相关性。
Int J Antimicrob Agents. 1998 Nov;10(4):271-7. doi: 10.1016/s0924-8579(98)00050-8.
5
Multicentre surveillance of antimicrobial resistance in enterococci and staphylococci from Colombian hospitals, 2001-2002.2001 - 2002年哥伦比亚医院肠球菌和葡萄球菌耐药性的多中心监测
J Antimicrob Chemother. 2003 Jan;51(1):59-68. doi: 10.1093/jac/dkg002.
6
Activity of daptomycin against multi-resistant Gram-positive bacteria including enterococci and Staphylococcus aureus resistant to linezolid.达托霉素对包括对利奈唑胺耐药的肠球菌和金黄色葡萄球菌在内的多重耐药革兰氏阳性菌的活性。
Int J Antimicrob Agents. 2004 Oct;24(4):315-9. doi: 10.1016/j.ijantimicag.2004.04.006.
7
Frequency of isolation and antimicrobial resistance of gram-negative and gram-positive bacteria from patients in intensive care units of 25 European university hospitals participating in the European arm of the SENTRY Antimicrobial Surveillance Program 1997-1998.参与1997 - 1998年哨兵抗菌监测计划欧洲部分的25家欧洲大学医院重症监护病房患者中革兰氏阴性菌和革兰氏阳性菌的分离频率及抗菌药物耐药性
Eur J Clin Microbiol Infect Dis. 2001 Sep;20(9):617-25. doi: 10.1007/s100960100564.
8
Susceptibility to tigecycline and linezolid among gram-positive isolates collected in the United States as part of the tigecycline evaluation and surveillance trial (TEST) between 2004 and 2009.2004 年至 2009 年期间,在美国进行的替加环素评估和监测试验(TEST)中收集的革兰氏阳性分离株对替加环素和利奈唑胺的敏感性。
Clin Ther. 2011 Dec;33(12):1964-73. doi: 10.1016/j.clinthera.2011.10.010. Epub 2011 Nov 10.
9
Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004).亚太地区革兰氏阳性菌分离株的抗菌药敏性以及达托霉素、万古霉素和替考拉宁杀菌活性的体外评估:哨兵计划报告(2003 - 2004年)
Int J Antimicrob Agents. 2007 Aug;30(2):143-9. doi: 10.1016/j.ijantimicag.2007.03.015. Epub 2007 May 24.
10
Evaluation of tedizolid against Staphylococcus aureus and enterococci with reduced susceptibility to vancomycin, daptomycin or linezolid.评价替加环素对金黄色葡萄球菌和对万古霉素、达托霉素或利奈唑胺敏感性降低的肠球菌的抗菌活性。
J Antimicrob Chemother. 2016 Jan;71(1):152-5. doi: 10.1093/jac/dkv302. Epub 2015 Oct 16.

引用本文的文献

1
Frequency and antibiotic susceptibility of gram-positive bacteria in Makkah hospitals.麦加医院革兰氏阳性菌的频率及抗生素敏感性
Ann Saudi Med. 2011 Sep-Oct;31(5):462-8. doi: 10.4103/0256-4947.84622.
2
Pharmacokinetic/pharmacodynamic analysis of vancomycin in ICU patients.万古霉素在重症监护病房患者中的药代动力学/药效学分析。
Intensive Care Med. 2007 Feb;33(2):279-85. doi: 10.1007/s00134-006-0470-5. Epub 2006 Dec 13.
3
Sensitivity to detergents and plasmid curing in Enterococcus faecalis.粪肠球菌对去污剂的敏感性及质粒消除
J Ind Microbiol Biotechnol. 2006 Mar;33(3):238-42. doi: 10.1007/s10295-005-0261-y. Epub 2005 Jun 30.
4
Pharmacokinetics of teicoplanin in an ICU population of children and infants.替考拉宁在儿童重症监护病房患儿群体中的药代动力学。
Pharm Res. 2004 Nov;21(11):2064-71. doi: 10.1023/b:pham.0000048198.56873.d8.